Heart failure recognised in EU Safe Hearts Plan

News & Events

18 December 2025
AUTHOR: Lisa Hillman

The European Commission has formally recognised heart failure in its Safe Hearts Plan, marking a significant milestone for cardiovascular policy.

The plan takes an important step towards strengthening action on cardiovascular disease (CVD) by explicitly acknowledging the need to prevent heart failure and improve early detection, alongside broader efforts to strengthen cardiovascular health across Europe. This major advance follows sustained advocacy by our community through the European Heart Failure Mission campaign.

Where does heart failure appear in Safe Hearts Plan?

The plan includes three explicit references to heart failure, signalling growing recognition of its importance in the CVD landscape. Heart failure’s inclusion was far from guaranteed, and this progress reflects what the heart failure community can achieve.

Core definition of cardiovascular disease

Heart failure had been removed from the definition of CVD in a pre‑final draft. Its reinstatement in the final plan has set an important marker for future policy discussions:

“Cardiovascular diseases affect the heart and blood vessels. They include heart attacks, stroke, heart failure, ischaemic heart diseases, abnormal heart rhythms, structural heart diseases, cardiomyopathy and congenital heart diseases.” (p. 1)

Early detection of risk as part of screening

In Pillar 2: Early Detection and Screening of Those at Risk, the plan recognises that next‑generation cardiovascular screening must go beyond traditional risk factors and explicitly include early detection of heart failure risk:

“In addition to traditional screening areas, detection of kidney disease, and congenital conditions such as elevated lipoprotein(a)…as well as early detection of heart failure risk… should also be included in the scope of the screening.” (p. 16)

We are also encouraged to see kidney disease included alongside heart failure, reflecting the importance of an integrated approach to cardio-renal-metabolic conditions and multimorbidity.

Innovation and integrated care

In Pillar 3: Living with Cardiovascular Disease, the plan emphasises the importance of high‑quality, coordinated and patient‑centred care. It highlights the potential of integrated care models to improve quality of life and reduce unplanned admissions, with specific reference to heart failure:

“Integrated care models in primary care and community settings can… reduce unplanned hospital admissions and improve quality of life while saving costs… It is also possible to enhance and roll out innovative ICT‑enabled integrated care solutions tailored specifically to advance multi‑disciplinary health and care for patients with chronic heart failure.” (p. 19)

Looking ahead: next steps for heart failure advocacy

This achievement reflects the collective effort of the heart failure community and the strong engagement built with key members of EU institutions. We welcome the direction set out in the Safe Hearts Plan and remain committed to supporting the next phase of delivery.

Council Recommendations, health checks and screening protocols in 2026, followed by a likely shift towards person‑centred care and implementation from 2027 onwards, will be critical for shaping real‑world impact.

For the heart failure community, this includes continuing to advocate for:

As attention now turns to implementation, HFPN looks forward to working with EU institutions, Member States, and our members and partners – including the kidney and diabetes communities – to help ensure the plan tangibly improves the lives of people living with heart failure.

Tagged:

More from News & Events

New research sets out how to strengthen specialist heart fai
New research sets out how to strengthen specialist heart fai...
22 September 2026
The European Journal of Cardiovascular Nursing has published new research by the HFPN identifying urgent policy actions to strengthen specialist heart failure (HF) nursing in Europ...
Read article
Cardiovascular health checks: turning early detection into a
Cardiovascular health checks: turning early detection into a...
06 May 2026
CVD remains the European Union’s biggest health challenge. It is responsible for nearly one‑third of deaths and costs €282 billion each year. Heart failure – a leading ca...
Read article
The Heart Failure Policy Network is an independent, multidisciplinary platform made possible with financial support from AstraZeneca, Bayer and Roche Diagnostics. The content produced by the Network is not biased toward any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members. All members provide their time for free. The Network is hosted by The Health Policy Partnership. EU Transparency Register ID: 223430420230-66.